Illness	Number of cases
Heart failure (I50.01)	121
Left ventricular failure unspecified (I50.13)	103
Volume depletion (E86)	102
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	83
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	73
Essential primary hypertension (I10.01)	69
Chronic obstructive pulmonary disease with acute exacerbation (J44.19)	50
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	49
Chronic obstructive pulmonary disease with acute lower respiratory infection (J44.09)	39
Pneumonia organism unspecified - Lobar pneumonia unspecified organism (J18.1)	35

Top 10 treatments

Treatment	Number
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	318
(9-984.b)	312
(9-984.8)	303
(9-984.7)	261
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	190
Computed tomography of the chest with contrast medium (3-222)	190
Computed tomography (CT) of the head without contrast medium (3-200)	189
Computed tomography of the abdomen with contrast medium (3-225)	186
(9-984.9)	142
Examination of the large intestine by endoscopy - colonoscopy (1-650.2)	118

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
13	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
3	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
3	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility